ERNA vs SRPT · P/E 0.0, rev $582.0K vs rev $1.90B
Eterna Therapeutics Inc (ERNA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ERNA and SRPT stock pages for the full models.
Not investment advice.